KORU Medical Systems, Inc. (KRMD)
NASDAQ: KRMD · Real-Time Price · USD
4.360
+0.150 (3.56%)
Mar 23, 2026, 12:45 PM EDT - Market open

Company Description

KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally.

The company offers the FREEDOM infusion systems to deliver therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobinuria (PNH).

Its products include the FREEDOM60 Syringe Driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing.

The company was formerly known as Repro Med Systems, Inc. and changed its name to KORU Medical Systems, Inc. in March 2022.

KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Mahwah, New Jersey.

KORU Medical Systems, Inc.
KORU Medical Systems logo
CountryUnited States
Founded1980
IndustryMedical Instruments & Supplies
SectorHealthcare
Employees73
CEOLinda Tharby

Contact Details

Address:
100 Corporate Drive
Mahwah, New Jersey 07430
United States
Phone845-469-2042
Websitekorumedical.com

Stock Details

Ticker SymbolKRMD
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code704440
CUSIP Number759910102
ISIN NumberUS7599101026
Employer ID13-3044880
SIC Code3841

Key Executives

NamePosition
Thomas AdamsChief Financial Officer, Secretary and Treasurer

Latest SEC Filings

DateTypeTitle
Mar 16, 20268-KCurrent Report
Mar 12, 202610-KAnnual Report
Mar 12, 20268-KCurrent Report
Feb 17, 2026SCHEDULE 13G/AFiling
Feb 13, 2026SCHEDULE 13G/AFiling
Feb 13, 2026SCHEDULE 13D/AFiling
Feb 11, 20268-KCurrent Report
Jan 21, 2026SCHEDULE 13GFiling
Jan 12, 20268-KCurrent Report
Jan 5, 2026S-8Securities to be offered to employees in employee benefit plans